Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock
September 02, 2025 21:33 ET | Source: Mineralys Therapeutics, Inc. RADNOR, Pa.,…
CHARM Therapeutics raises $80 million in Series B financing to advance development of best-in-class menin inhibitor for AML
New investors NEA and SR One lead round alongside existing investors OrbiMed,…
Vantage Launches “Race to Win: Live Trading Contest 2025” with up to $1 Million Prize Pool
PORT VILA, Vanuatu, Sept. 1, 2025 /PRNewswire/ -- Vantage is pleased to announce…
Bybit Spot Lists WLFI with 1.6 Million WLFI in Prizes
DUBAI, UAE, Sept. 1, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency…
Picard Medical, Inc. Announces Pricing of $17 Million Initial Public Offering
August 28, 2025 19:36 ET | Source: Picard Medical, Inc. TUCSON, Ariz.,…
Commonwealth Fusion Systems Raises $863 Million Series B2 Round to Accelerate the Commercialization of Fusion Energy
This round of capital is the largest raised among deep tech and…
Cognition Therapeutics Announces $30 Million Registered Direct Offering of Common Stock
August 27, 2025 20:53 ET | Source: Cognition Therapeutics, Inc. - The…
JAMining Announces Milestone of Over 8 Million Registered Users Driving Global Expansion
JAMining reaches 8+ million users across 60+ countries, reporting $150+ million annual…
Invivyd Announces Closing of $57.5 Million Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares
August 22, 2025 12:00 ET | Source: Invivyd WALTHAM, Mass., Aug. 22,…
Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters Over-Allotment Option
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE…
